A Study of Two Versus Three Daily Injections in Children and Adolescents With Newly Diagnosed Type 1 Diabetes
Diabetes Mellitus, Type 1
About this trial
This is an interventional treatment trial for Diabetes Mellitus, Type 1 focused on measuring Diabetes Mellitus, Type 1, Child, Adolescent, Disease Management, Newly Diagnosed, Hemoglobin A, Glycosylated
Eligibility Criteria
Inclusion Criteria: New onset type 1 diabetes Less than 48 hours since first insulin injection Child and/or parent able to read and write English Family intends to continue treatment at our institution for the next two years Informed consent from adolescents greater than 16 years of age, or if less than 16 years, informed consent from the parent/guardian with assent from the child. Exclusion Criteria: Chronic medical conditions other than treated hypothyroidism or mild asthma Concerns of the diabetes team regarding future treatment adherence making twice daily insulin preferable to the split evening injection regimen (e.g., cognitive impairment, severe family dysfunction).
Sites / Locations
- Children's Hospital of Eastern Ontario